Source: Public Filings
ENTITY
Shanghai Henlius Biotech (2696 HK)
Shanghai Henlius Biotech (2696 HK)
69
Analysis
Health Care • China
Shanghai Henlius Biotech, Inc develops and produces drugs. The Company develops and produces monoclonal antibody biosimilar drugs, bio betters, novel monoclonal antibodys, and other drugs. Shanghai Henlius Biotech throughout China.
more
x